The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing
Authors:
- Louisa L LoLLLouisa L Lo
- Ian M CollinsICIan M Collins
- Mathias BresselMBMathias Bressel
- Phyllis ButowPBPhyllis Butow
- Jon EmeryJEJon Emery
- Louise KeoghLKLouise Keogh
- Prue WeidemanPWPrue Weideman
- Emma SteelESEmma Steel
- John L HopperJHJohn L Hopper
- Alison H TrainerATAlison H Trainer
- Gregory B MannGMGregory B Mann
- Adrian BickerstaffeABAdrian Bickerstaffe
Open Access
- 7 November 2018
- journal article
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 2 (2) , e24
Abstract
Background: iPrevent estimates breast cancer (BC) risk and provides tailored risk management information. Objective: The objective of this study was to assess the usability and acceptability of the iPrevent prototype. Methods: Clinicians were eligible for participation in the study if they worked in primary care, breast surgery, or genetics clinics. Female patients aged 18-70 years with no personal cancer history were eligible. Clinicians were first familiarized with iPrevent using hypothetical paper-based cases and then actor scenarios; subsequently, they used iPrevent with their patients. Clinicians and patients completed the System Usability Scale (SUS) and an Acceptability questionnaire 2 weeks after using iPrevent; patients also completed measures of BC worry, anxiety, risk perception, and knowledge pre- and 2 weeks post-iPrevent. Data were summarized using descriptive statistics. Results: The SUS and Acceptability questionnaires were completed by 19 of 20 clinicians and 37 of 43 patients. Usability was above average (SUS score >68) for 68% (13/19) clinicians and 76% (28/37) patients. The amount of information provided by iPrevent was reported as “about right” by 89% (17/19) clinicians and 89% (33/37) patients and 95% (18/19) and 97% (36/37), respectively, would recommend iPrevent to others, although 53% (10/19) clinicians and 27% (10/37) patients found it too long. Exploratory analyses suggested that iPrevent could improve risk perception, decrease frequency of BC worry, and enhance BC prevention knowledge without changing state anxiety. Conclusions: The iPrevent prototype demonstrated good usability and acceptability. Because concerns about length could be an implementation barrier, data entry has been abbreviated in the publicly available version of iPrevent.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment ModelsJNCI: Journal of the National Cancer Institute, 2010
- Development and preliminary evaluation of a bowel cancer screening decision aid for adults with lower literacyPatient Education and Counseling, 2009
- The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsBritish Journal of Cancer, 2008
- The GRAIDS Trial: The development and evaluation of computer decision support for cancer genetic risk assessment in primary careAnnals of Human Biology, 2005
- Development of a risk assessment tool for women with a family history of breast cancerCancer Detection Prevention, 2005
- Prevention and genetic testing for breast cancer: variations in medical decisionsSocial Science & Medicine, 2004
- A breast cancer prediction model incorporating familial and personal risk factorsStatistics in Medicine, 2004
- Attitudes to genetic testing for breast cancer susceptibility in women at increased risk of developing hereditary breast cancerJournal of Medical Genetics, 2000
- The development of a six‐item short‐form of the state scale of the Spielberger State—Trait Anxiety Inventory (STAI)British Journal of Clinical Psychology, 1992
- Psychological side effects of breast cancer screening.Health Psychology, 1991